Tweet
Alflutop is a natural, injectable formula that is reported to be more effective than corticosteroid injections, as it not only reduces inflamation, but encourages repair and regeneration of cartilage and connective tissue. Alflutop has proven effective in clinical trials in degenerative joint disorders (bursitis, tendonitis, and arthritis). Comparable in effect, though different in formula from Adequan, Alflutop is reported to be a miracle drug for joint injuries. Alflutop is manufactured by BIOTEHNOS S.A. Romania, and is not approved by the FDA.
Description:
Each 1ml ampule of Alflutop contains 10 mg sea fish bioactive concentrate (amino acids, low molecular mass peptides, mucopolysaccharides, trace elements: Na, K, Ca, Mg, Fe, Cu, Zn), and maximum 5mg/100ml phenol as preservative.
How it works:
Alflutop falls into the group of chondroprotective products having anti-hyaluronidase, anti-inflammatory and analgesic action. Alflutop:
inhibits hyaluronidase excess;
restores chondrocytes homeostasis in damaged tissues;
stimulates regenerative processes at cartilage level;
adjusts synovial fluid synthesis;
stimulates superoxide dismutase;
inhibits occurrence of superoxide free radicals.
Dosing:
Intramuscular (IM) injection of 1 amp every day for 3 weeks, for a 21 day cycle, which can be followed up 2 months later. Intra-articular (IA) injection has also shown effective in later-stage clinical trials. 1-2 amps into the joint, E3D for 21 days.
If it's all the same, I think I'd go for the IM route. Not too big a fan of the prospect of stabbing through some cartilage or tendons, personally. There is probably little benefit, if any, to a local IM injection (close proximity to the injured joint), so I would skip it. You probably stand to do more harm than good by "threading the needle", so to speak, into your injured joint.
Alflutop has an active life of approximately 24-36 hours. The dosing protocols above are just guidelines, and the bottom line is you should continue treatment as long as necessary, if need be. There are no indications of toxicity, or any other negative side effects from Alflutop.
Clinical Trial Results:
The clinical trials have confirmed the efficacy of Alflutop in degenerative articular, post-traumatic pathology and abarticular rheumatism:
extremely few adverse reactions;
lack of major complications;
well tolerated, including the patients sufferring from gastrointestinal, cardiovascular and metabolic diseases; and
a favourable ratio of costs and clinical efficacy.
The clinical trials showed the therapeutical effect of Alflutop in the treatment of periarthritis, spondiloarthrosis, spinal disc injuries, ankylopoietic spondilitis, Reiter syndrome, and rheumatoid polyarthritis.
Description:
Each 1ml ampule of Alflutop contains 10 mg sea fish bioactive concentrate (amino acids, low molecular mass peptides, mucopolysaccharides, trace elements: Na, K, Ca, Mg, Fe, Cu, Zn), and maximum 5mg/100ml phenol as preservative.
How it works:
Alflutop falls into the group of chondroprotective products having anti-hyaluronidase, anti-inflammatory and analgesic action. Alflutop:
inhibits hyaluronidase excess;
restores chondrocytes homeostasis in damaged tissues;
stimulates regenerative processes at cartilage level;
adjusts synovial fluid synthesis;
stimulates superoxide dismutase;
inhibits occurrence of superoxide free radicals.
Dosing:
Intramuscular (IM) injection of 1 amp every day for 3 weeks, for a 21 day cycle, which can be followed up 2 months later. Intra-articular (IA) injection has also shown effective in later-stage clinical trials. 1-2 amps into the joint, E3D for 21 days.
If it's all the same, I think I'd go for the IM route. Not too big a fan of the prospect of stabbing through some cartilage or tendons, personally. There is probably little benefit, if any, to a local IM injection (close proximity to the injured joint), so I would skip it. You probably stand to do more harm than good by "threading the needle", so to speak, into your injured joint.
Alflutop has an active life of approximately 24-36 hours. The dosing protocols above are just guidelines, and the bottom line is you should continue treatment as long as necessary, if need be. There are no indications of toxicity, or any other negative side effects from Alflutop.
Clinical Trial Results:
The clinical trials have confirmed the efficacy of Alflutop in degenerative articular, post-traumatic pathology and abarticular rheumatism:
extremely few adverse reactions;
lack of major complications;
well tolerated, including the patients sufferring from gastrointestinal, cardiovascular and metabolic diseases; and
a favourable ratio of costs and clinical efficacy.
The clinical trials showed the therapeutical effect of Alflutop in the treatment of periarthritis, spondiloarthrosis, spinal disc injuries, ankylopoietic spondilitis, Reiter syndrome, and rheumatoid polyarthritis.
Comment